Westfield Capital Management Co. LP raised its stake in Option Care Health, Inc. (NASDAQ:OPCH – Free Report) by 19.6% during the fourth quarter, according to the company in its most recent Form 13F filing with the SEC. The institutional investor owned 4,482,732 shares of the company’s stock after buying an additional 735,344 shares during the quarter. Option Care Health comprises approximately 0.9% of Westfield Capital Management Co. LP’s investment portfolio, making the stock its 21st biggest holding. Westfield Capital Management Co. LP owned 2.53% of Option Care Health worth $151,023,000 as of its most recent SEC filing.
Several other institutional investors have also added to or reduced their stakes in OPCH. Principal Securities Inc. bought a new position in Option Care Health during the fourth quarter worth about $27,000. Headlands Technologies LLC lifted its position in shares of Option Care Health by 5,796.7% during the 3rd quarter. Headlands Technologies LLC now owns 1,769 shares of the company’s stock worth $57,000 after buying an additional 1,739 shares during the last quarter. Fifth Third Bancorp boosted its stake in shares of Option Care Health by 219.6% in the 3rd quarter. Fifth Third Bancorp now owns 2,723 shares of the company’s stock valued at $88,000 after purchasing an additional 1,871 shares in the last quarter. Parkside Financial Bank & Trust boosted its position in Option Care Health by 24,250.0% in the fourth quarter. Parkside Financial Bank & Trust now owns 2,922 shares of the company’s stock valued at $98,000 after buying an additional 2,910 shares in the last quarter. Finally, International Assets Investment Management LLC boosted its holdings in shares of Option Care Health by 1,513.7% during the 4th quarter. International Assets Investment Management LLC now owns 3,066 shares of the company’s stock valued at $103,000 after acquiring an additional 2,876 shares in the last quarter. 98.05% of the stock is owned by institutional investors.
Option Care Health Trading Up 1.5 %
Shares of Option Care Health stock traded up $0.44 on Friday, reaching $29.04. 871,109 shares of the company’s stock were exchanged, compared to its average volume of 1,299,427. Option Care Health, Inc. has a 52 week low of $26.17 and a 52 week high of $35.74. The company has a debt-to-equity ratio of 0.74, a quick ratio of 1.39 and a current ratio of 1.77. The company has a market capitalization of $5.05 billion, a P/E ratio of 19.11, a price-to-earnings-growth ratio of 1.41 and a beta of 1.26. The firm’s 50-day moving average is $30.88 and its two-hundred day moving average is $31.41.
Analyst Upgrades and Downgrades
OPCH has been the subject of several recent research reports. Jefferies Financial Group upped their price objective on Option Care Health from $36.00 to $38.00 and gave the company a “buy” rating in a research note on Monday, March 4th. Barrington Research reissued an “outperform” rating and issued a $38.00 price target on shares of Option Care Health in a research note on Wednesday, April 24th.
Check Out Our Latest Report on OPCH
Insiders Place Their Bets
In other news, Director Harry M. Jansen Kraemer, Jr. purchased 35,000 shares of the company’s stock in a transaction that occurred on Monday, February 26th. The shares were bought at an average cost of $31.55 per share, with a total value of $1,104,250.00. Following the completion of the transaction, the director now directly owns 269,528 shares of the company’s stock, valued at $8,503,608.40. The acquisition was disclosed in a legal filing with the Securities & Exchange Commission, which is available at this hyperlink. Corporate insiders own 0.64% of the company’s stock.
Option Care Health Profile
Option Care Health, Inc offers home and alternate site infusion services in the United States. The company provides anti-infective therapies; home infusion services to treat heart failures; home parenteral nutrition and enteral nutrition support services for numerous acute and chronic conditions, such as stroke, cancer, and gastrointestinal diseases; immunoglobulin infusion therapies for the treatment of immune deficiencies; and treatments for chronic inflammatory disorders, including crohn's disease, plaque psoriasis, psoriatic arthritis, rheumatoid arthritis, ulcerative colitis, and other chronic inflammatory disorders.
Read More
- Five stocks we like better than Option Care Health
- What Are Dividend Achievers? An Introduction
- NASDAQ 100 vs. NASDAQ Composite: A Detailed Breakdown of NASDAQ
- The 3 Best Blue-Chip Stocks to Buy Now
- These 2 Retail Traders Favorites are Nearing Major Breakouts
- What is Put Option Volume?
- Snowflake is Melting… Up, With a Double-Digit Upside Potential
Receive News & Ratings for Option Care Health Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Option Care Health and related companies with MarketBeat.com's FREE daily email newsletter.